Navigation Links
Kappa Alpha Psi Fraternity, Inc. Announces Major Partnership to Focus on Children's Health
Date:5/7/2008

PHILADELPHIA, May 7 /PRNewswire/ -- Kappa Alpha Psi Fraternity, Inc. announced today it is coordinating a major initiative with a nationwide network of churches and its ongoing partnership with the St. Jude Children's Research Hospital and their work to eradicate cancer in children to concentrate attention, resources and volunteerism efforts on combating illness and disease inflicting children.

Grand Polemarch Dwayne M. Murray, announcing the plan said, "When we look at cancer, obesity, asthma, malnutrition, and health issues like high blood pressure, a disproportionate number of children in communities across the country are suffering and we need to do something to change that unfortunate fact."

The partnership initially focuses on the efforts of St. Jude Children's Research Hospital and is expected to raise nearly $300,000 this year to assist with St. Jude's enormous efforts to treat children suffering from cancer and other chronic diseases.

The fraternity's 650 Undergraduate and Alumni Chapters have coordinated with more than 500 churches to help raise much needed financial resources and establish a network of community organizations to help raise awareness in underserved communities.

"Along with churches," Murray said, "we can extend our energy and reach far beyond our traditional base of campuses and communities where our chapters are anchored."

Kappa Alpha Psi Fraternity, Inc. is an international organization founded on the campus of Indiana University, Bloomington, Indiana on January 5, 1911. Since its inception, it has trained over 125,000 men, particularly undergraduates, for leadership roles in their communities and the attainment of a high degree of excellence in their academic pursuits. The International Headquarters is located in Philadelphia, Pennsylvania.


'/>"/>
SOURCE Kappa Alpha Psi Fraternity, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership
2. AlphaRx To Present at 47th Annual ICAAC
3. Are You An AlphaWell or An OhWell?
4. AlphaRx Announces Debt Conversion
5. AlphaDetail, Inc. Affirms Commitment to Local East Coast Presence
6. Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities
7. Free Program Dec. 1 to Help Patients With Debilitating Pulmonary Disorder Alpha-1
8. AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares
9. AlphaRx CEO Accumulates More Company Shares
10. TNF-alpha antagonist stops inflammation-induced colon cancer in its tracks
11. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
(Date:11/21/2008)...one day lead to a novel technique to combat cancer...althDay News) -- Belgian researchers have discover...of sugar for food, and this might lead to new trea...urvive and proliferate, all cells in the body need...[glucose], a process that requires oxygen. Compare...
(Date:11/21/2008)...ders Intend To Vigorously Protect Investment And R...v. 21 Dr. Stephen Joffe...dment to their Schedule 13D with the U.S. Securiti...filed a 13D disclosing ownership of 11.4% of LCA-V...asikPlus fixed-site laser vision correction center...
(Date:11/21/2008)..., Nov. 21 Barr Pharmaceu...ts shareholders overwhelmingly approved the propos...of Barr by Teva Pharmaceuticals Industries Ltd. (N...rated the overwhelming support of the transaction ...arr,s Chairman and CEO. "We are pleased with the p...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
... left for herself to cremate the body of her husba...ve a helping hand. The widow dragged his body to t...s herself. Grief-stricken Dhanua Devi (named chang...llage in Darbhanga district, says not a single per...
... the set-up of a public Health foundation of India...n of health care services in the country. // This ...ess the inequalities in financial management of re...tribution of specializations in health care servic...
...f the potentially-fatal condition of pre-eclampsi...s of Vitamin C and E. // Recent research has sugg...ial to pregnant women and can trigger pre-eclampsi...tion that causes an unhealthy rise of Blood pressu...
...very few patients were expected to come in. the ma...f dental charges to take effect next week. // This...eave the NHS. A survey showed that out of 45 local... that this would be the net result. The survey wa...
Other Medicine News:
(Date:11/20/2008)...ember 20 The Scandinavian-based dr...ced results of studies on its,lead antimicrobial ...n, DC,the studies showed that the novel lytic pe...ect, significantly better towards killing Staphylo...keted gold standard drugs. In,addition to this it...
(Date:11/19/2008).... 19 Biotech scientists increasing...y research to better understand the effects of nov...reports Genetic Engineering & Biotechnology N...guring out a new compound,s mechanism of action an...chnique, according to the November 15 issue of GE...
(Date:11/18/2008)...PRNewswire/ -- Arlington Medical Resources (AMR), ... pharmaceutical and diagnostic,imaging industries...vigen was,sold in the U.S. during the third quart...venous immune globulin (IVIG) and was launched in ...ted from the blood plasma of thousands,of donors ...
(Date:11/13/2008)...Nutritional Supplements Prior to Surgery, ARLINGT...-- Identifying,malnutrition before surgery in mass...ill significantly decrease surgical complications,...d boost patient energy levels,according to a stud...ive,Surgery(R), the official medical journal of th...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Molecule Keeps Bacteria Like Salmonella in Check 25681 1Molecule Keeps Bacteria Like Salmonella in Check 25681 2 AdvancedMD Named to Inc 5000 List of America 26apos 3Bs Fastest Growing Companies 3A Web based Software Leader Ranked No 44 in the Top 100 Softwa 25678 1 AdvancedMD Named to Inc 5000 List of America 26apos 3Bs Fastest Growing Companies 3A Web based Software Leader Ranked No 44 in the Top 100 Softwa 25678 2Zeus Webinar 3A Bioabsorbable Polymers as Biomaterials 7286 1Zeus Webinar 3A Bioabsorbable Polymers as Biomaterials 7286 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 1Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 5
...hoc analysis shows nearly nine out of ten patients... the end of 12 months, WASHINGTON, D.C., May 22, 2...I, open-label 12-14 month extension study (303),pr... (BSG) meeting,in Glasgow, Scotland in March 2007 ...rated in mild to moderate UC,patients. Today, seco...
...Zeneca Focuses Research on Growing Childhood Condi...ll/ -- AstraZeneca,will present several studies to...geal reflux disease (GERD) during oral and poster,...ing held at the,Washington Convention Center. , Th...eca,s,commitment to research in the area of gastro...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 2New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 3New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 4New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 5
Colloidal Gold Conjugated, Streptavidin - 50 OD
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD
Colloidal Gold Conjugated, Goat anti-human IgG (H&L) - 50 OD
Colloidal Gold Conjugated, Protein A - 50 OD
Medicine Products: